Asian Phytoceuticals PCL (BKK:APCO-R) Cyclically Adjusted Revenue per Share: ฿1.37 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:APCO-R Asian Phytoceuticals PCL BKK:APCO-R
63 GF Score
Price ฿6.27
GF Value ฿7.68
! 4 Warning Signs
View Full Analysis

What is Asian Phytoceuticals PCL Cyclically Adjusted Revenue per Share?

Asian Phytoceuticals PCL BKK:APCO-R 63 Cyclically Adjusted Revenue per Share is ฿1.37 as of Jun. 2026. GuruFocus rates BKK:APCO-R with a GF Score™ of 63/100 and a GF Value™ of ฿7.68. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Asian Phytoceuticals PCL's adjusted revenue per share for the three months ended in Jun. 2026 was ฿0.084. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ฿1.37 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Asian Phytoceuticals PCL's average Cyclically Adjusted Revenue Growth Rate was -8.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -3.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Asian Phytoceuticals PCL was -1.10% per year. The lowest was -3.20% per year. And the median was -2.00% per year.

As of today (2026-08-31), Asian Phytoceuticals PCL's current stock price is ฿6.2739. Asian Phytoceuticals PCL's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ฿1.37. Asian Phytoceuticals PCL's Cyclically Adjusted PS Ratio of today is 4.58.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Asian Phytoceuticals PCL was 12.34. The lowest was 4.38. And the median was 7.50.


Asian Phytoceuticals PCL  (BKK:APCO-R) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Asian Phytoceuticals PCL's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=6.2739/1.37
=4.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Asian Phytoceuticals PCL was 12.34. The lowest was 4.38. And the median was 7.50.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Asian Phytoceuticals PCL Cyclically Adjusted Revenue per Share Related Terms


Asian Phytoceuticals PCL Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Asian Phytoceuticals PCL's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asian Phytoceuticals PCL Cyclically Adjusted Revenue per Share Chart

Asian Phytoceuticals PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.65 0.76 0.78 1.27

Asian Phytoceuticals PCL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.18 1.14 1.27 1.32 1.37

BKK:APCO-R vs PG, CL, EL: Cyclically Adjusted Revenue per Share Comparison

For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asian Phytoceuticals PCL Cyclically Adjusted PS Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Asian Phytoceuticals PCL's Cyclically Adjusted PS Ratio falls into.


BKK:APCO-R
63GF Score
Asian Phytoceuticals PCL BKK:APCO-R
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asian Phytoceuticals PCL Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Asian Phytoceuticals PCL's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.084/333.9520*333.9520
=0.084

Current CPI (Jun. 2026) = 333.9520.

Asian Phytoceuticals PCL Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.189 241.428 0.261
201612 0.174 241.432 0.241
201703 0.157 243.801 0.215
201706 0.170 244.955 0.232
201709 0.185 246.819 0.250
201712 0.181 246.524 0.245
201803 0.151 249.554 0.202
201806 0.130 251.989 0.172
201809 0.149 252.439 0.197
201812 0.168 251.233 0.223
201903 0.148 254.202 0.194
201906 0.099 256.143 0.129
201909 0.095 256.759 0.124
201912 0.095 256.974 0.123
202003 0.107 258.115 0.138
202006 0.090 257.797 0.117
202009 0.103 260.280 0.132
202012 0.111 260.474 0.142
202103 0.080 264.877 0.101
202106 0.099 271.696 0.122
202109 0.092 274.310 0.112
202112 0.104 278.802 0.125
202203 0.092 287.504 0.107
202206 0.097 296.311 0.109
202209 0.105 296.808 0.118
202212 0.124 296.797 0.140
202303 0.139 301.836 0.154
202306 0.115 305.109 0.126
202309 0.128 307.789 0.139
202312 0.107 306.746 0.116
202403 0.100 312.332 0.107
202406 0.075 314.175 0.080
202409 0.079 315.301 0.084
202412 0.081 315.605 0.086
202503 0.076 319.799 0.079
202506 0.075 322.561 0.078
202509 0.068 324.800 0.070
202512 0.072 324.054 0.074
202603 0.085 330.213 0.086
202606 0.084 333.952 0.084

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ฿1.37 mean?
Asian Phytoceuticals PCL (BKK:APCO-R) has a Cyclically Adjusted Revenue per Share of ฿1.37 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Asian Phytoceuticals PCL and its competitors.
Is Asian Phytoceuticals PCL's Cyclically Adjusted Revenue per Share too high?
Asian Phytoceuticals PCL's current Cyclically Adjusted Revenue per Share is ฿1.37. Overall, Asian Phytoceuticals PCL has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's Cyclically Adjusted Revenue per Share compare to PG and CL?
Asian Phytoceuticals PCL's Cyclically Adjusted Revenue per Share of ฿1.37 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted Revenue per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Asian Phytoceuticals PCL and its competitors. Asian Phytoceuticals PCL's current Cyclically Adjusted Revenue per Share is ฿1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current Cyclically Adjusted Revenue per Share of ฿1.37. The stock's GF Value™ is ฿7.68, compared to a current price of ฿6.27 — trading 18.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ฿1.37. Asian Phytoceuticals PCL's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current Cyclically Adjusted Revenue per Share is ฿1.37 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?

Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued. The current stock price of ฿6.27 is trading 18.3% below its estimated GF Value™ of ฿7.68.

Key valuation signals for BKK:APCO-R:

  • Cyclically Adjusted Revenue per Share: ฿1.37
  • GF Value™: ฿7.68 vs. price of ฿6.27 (18.3% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Asian Phytoceuticals PCL Business Description

Other Exchanges APCO:Thailand
Address 84/3 Moo 4 Highway No.11 Road, Northern Region Industrial Estate West, Banklang, Muang Lamphun, Lumphun, THA, 51000
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
63GF Score

Get the complete analysis for BKK:APCO-R

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿6.27
Price
฿7.68
GF Value